BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3000794)

  • 1. Long-term low dose ticlopidine treatment in rheumatoid arthritis: effects on serum sulphydryl levels, technetium index, erythrocyte sedimentation rate, and clinical disease activity.
    Grimaldi MG
    Eur J Clin Pharmacol; 1985; 29(2):165-8. PubMed ID: 3000794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term cyclophosphamide treatment in rheumatoid patients: effects on serum sulphydryl levels, technetium index, ESR and clinical response.
    Grimaldi MG
    Br J Clin Pharmacol; 1981 Oct; 12(4):503-6. PubMed ID: 7295485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term low dose haloperidol treatment in rheumatoid patients: effects on serum sulphydryl levels, technetium index, ESR, and clinical response.
    Grimaldi MG
    Br J Clin Pharmacol; 1981 Oct; 12(4):579-81. PubMed ID: 7295491
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum sulfhydryl levels in rheumatoid patients treated with haloperidol.
    Grimaldi MG
    Scand J Rheumatol; 1980; 9(4):225-8. PubMed ID: 7455635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sulfhydryl levels in rheumatoid patients treated with cyclophosphamide.
    Grimaldi MG
    Scand J Rheumatol; 1980; 9(4):237-40. PubMed ID: 7455636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between clinical and laboratory findings when the whole blood filterability rate is modified by ticlopidine in the treatment of rheumatoid arthritis.
    Ciuffetti G; Ciacca A; Mercuri M; Lombardini R; Maragoni G; Scarponi AM
    Br J Rheumatol; 1989 Oct; 28(5):424-7. PubMed ID: 2790405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum sulphydryl concentrations and antirheumatic drugs in rheumatoid patients.
    Grimaldi MG
    J Pharm Pharmacol; 1980 Dec; 32(12):876. PubMed ID: 6110764
    [No Abstract]   [Full Text] [Related]  

  • 8. [Concentration of serum sulphydryl groups in patients with rheumatoid arthritis dependent on age and duration of disease].
    Janiszewski M; Gaweda J; Drzewoski J
    Wiad Lek; 1994 Sep; 47(17-18):654-8. PubMed ID: 7571613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value and limitations of scintigraphy of the hand in rheumatoid arthritis].
    Scutellari PN; Orzincolo C; Feggi LM; Delli Gatti I; Prandini N; Trotta F
    Minerva Med; 1985 Nov; 76(45-46):2213-8. PubMed ID: 3001587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum sulphydryl levels in rheumatoid patients treated with alclofenac.
    Evans PH
    Curr Med Res Opin; 1975; 3(5):268-75. PubMed ID: 241596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum copper and erythrocyte superoxide dismutase in rheumatoid arthritis.
    Banford JC; Brown DH; Hazelton RA; McNeil CJ; Sturrock RD; Smith WE
    Ann Rheum Dis; 1982 Oct; 41(5):458-62. PubMed ID: 7125714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of joint scintigraphy in rheumatoid arthritis].
    Shimabukuro K; Sakata H; Shirono K; Nakajo M; Shinohara S; Hashiguchi K; Kawasaki T; Sakou T
    Rinsho Hoshasen; 1983 Jan; 28(1):127-31. PubMed ID: 6302348
    [No Abstract]   [Full Text] [Related]  

  • 13. [Joint scintigraphy with 99Tcm pertechnetate in rheumatoid arthritis. The effects of therapy].
    Licata G; Scaglione R; Castello F
    Radiol Med; 1980 Oct; 66(10):765-7. PubMed ID: 6261304
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical and biochemical evaluation of etretinate in rheumatoid arthritis.
    Bird HA; Hill J; Sitton NG; Dixon JS; Wright V
    Rheumatol Int; 1988; 8(2):55-9. PubMed ID: 3041545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy study.
    Palosaari K; Vuotila J; Takalo R; Jartti A; Niemelä RK; Karjalainen A; Haapea M; Soini I; Tervonen O; Hakala M
    Rheumatology (Oxford); 2006 Dec; 45(12):1542-8. PubMed ID: 16670155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antioxidant activity and related variables in rheumatoid arthritis. Behaviour during sulphydrylant treatment.
    Ambanelli U; Spisni A; Ferraccioli GF
    Scand J Rheumatol; 1982; 11(4):203-7. PubMed ID: 7178856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antirheumatic drugs on protein sulphydryl reactivity of human serum.
    Hall NC; Gillan AH
    J Pharm Pharmacol; 1979 Oct; 31(10):676-80. PubMed ID: 41040
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum copper and its relationship to clinical symptoms in rheumatoid arthritis.
    Brown DH; Buchanan WW; el-Ghobarey AF; Smith WE; Teape J
    Ann Rheum Dis; 1979 Apr; 38(2):174-6. PubMed ID: 443885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial.
    Dale J; Stirling A; Zhang R; Purves D; Foley J; Sambrook M; Conaghan PG; van der Heijde D; McConnachie A; McInnes IB; Porter D
    Ann Rheum Dis; 2016 Jun; 75(6):1043-50. PubMed ID: 27026689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
    Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
    Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.